⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 24, 2006Antimicrobial Agents and ChemotherapyOpen Access

β-Lactam MICs Correlate Poorly with Mutant Prevention Concentrations for Clinical Isolates of Acinetobacter spp. and Pseudomonas aeruginosa

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Universidade Federal de São Paulo, Div Infect Dis, Lab Alerta, São Paulo, Brazil

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Gugel et al. (2006) studied this question.

synapsesocial.com/papers/6a896ee85bf201f606719d9f https://doi.org/10.1128/aac.00144-06

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Restricting the Selection of Antibiotic‐Resistant Mutants: A General Strategy Derived from Fluoroquinolone StudiesOriginal Research · 2001 · 401 citations
2Mutant prevention concentrations of ciprofloxacin for urinary tract infection isolates of Escherichia coliOriginal Research · 2005 · 86 citations
3DNA topoisomerase targets of the fluoroquinolones: A strategy for avoiding bacterial resistanceOriginal Research · 1997 · 214 citations
4Antimicrobial Resistance among <i>Streptococcus pneumoniae</i> in the United States: Have We Begun to Turn the Corner on Resistance to Certain Antimicrobial Classes?Original Research · 2005 · 198 citations
5Selection of Streptococcus pneumoniae Mutants Having Reduced Susceptibility to Moxifloxacin and LevofloxacinOriginal Research · 2002 · 98 citations